A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

NCT06901531 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Metastatic Gastric Adenocarcinoma or Cancer
Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

Interventions

DRUG: zolbetuximab
DRUG: Pembrolizumab
DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Folinic acid (leucovorin or local equivalent)
DRUG: 5-fluorouracil (5-FU)
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.